Development of a Novel PET Radioligand for Imaging the Adenosine A 2A Receptor in the Brain
- 22 December 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 17 (1) , 231-238
Abstract
The adenosine A2A receptor (A2AAR) is implicated in the pathogenesis of neurodegenerative diseases, including Alzheimer's disease, due to its involvement in neuroinflammatory processes and synaptic function. However, suitable positron emission tomography (PET) radioligands for direct imaging of A2AAR in the living brain remain limited. In this study, we describe the synthesis and preclinical evaluation of [11C]2, a novel PET radioligand developed to target A2AAR with moderate affinity and selectivity. [11C]2 was synthesized with high radiochemical purity and satisfactory molar activity. In vivo PET imaging in wild-type mice demonstrated that [11C]2 efficiently crossed the blood-brain barrier and distributed throughout the brain. Blocking studies with unlabeled compound 2 confirmed the specificity of [11C]2 binding in vivo. In vitro autoradiography further revealed regional binding patterns in both wild-type and Alzheimer's disease model mice. Slightly higher in vitro signals in AD model mice suggest a potential link to neuroinflammatory mechanisms, although further investigation is required. Notably, during the initial 0.5-2.5 min after injection, striatal uptake was modestly higher than in other brain regions; however, this advantage became indistinct at later time points. Thus, while [11C]2 enables very early phase mapping of A2AAR distribution, the transient nature of its striatal preference indicates that further structural optimization is required to enhance sustained striatal selectivity and overall imaging performance.Keywords
Funding Information
- National Institute on Aging (AG081195)
This publication has 39 references indexed in Scilit:
- Development and Preclinical Evaluation of PET Radiotracers Targeting Adenosine A1 ReceptorsACS Medicinal Chemistry Letters, 2025
- Design and Development of a Novel BET Protein-Targeted PET Imaging Probe for In Vivo Characterization of Alzheimer’s Disease PathophysiologyJournal of Medicinal Chemistry, 2025
- 18F-Labeled PET Tracers Specific for Adenosine A2A Receptor: Design, Synthesis, and Biological EvaluationACS Chemical Neuroscience, 2024
- Exploring the Immunomodulatory Properties of Red Onion (Allium cepa L.) Skin: Isolation, Structural Elucidation, and Bioactivity Study of Novel Onion Chalcones Targeting the A2A Adenosine ReceptorJournal of Agricultural and Food Chemistry, 2023
- Adenosine A2A receptor-bearing GABAergic neurons in the lateral septum of the brain: novel mediators of depressive-like behaviorPurinergic Signalling, 2023
- Striatopallidal adenosine A2A receptor modulation of goal-directed behavior: Homeostatic control with cognitive flexibilityNeuropharmacology, 2023
- Global insights into the fine tuning of human A2AAR conformational dynamics in a ternary complex with an engineered G protein viewed by NMRCell Reports, 2022
- Blockade of microglial adenosine A2A receptor suppresses elevated pressure‐induced inflammation, oxidative stress, and cell death in retinal cellsGlia, 2019
- Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitryProgress in Neurobiology, 2007
- Evaluation of distribution of adenosine A2A receptors in normal human brain measured with [11C]TMSX PETSynapse, 2007